Clinical Medicine and Diagnostics

p-ISSN: 2163-1433     e-ISSN: 2163-1441

20111(1): 17-20

doi: 10.5923/j.cmd.20110101.03

Pituitary Adenoma Complicated by Multifocal Fibrosclerosis Involving Sella and Retroperitoneum

Copyright © 2011 Scientific & Academic Publishing. All Rights Reserved.

Abstract

Multifocal fibrosclerosis (MFS) is a rare syndrome characterized by the co-occurrence of two or more fibrosing diseases thought to be of similar pathogenesis.Rarely, central nervous system manifestations of pachymeningitis or sellar/suprasellar fibrosis have been described.We report a patient with a pituitary adenoma with extensive fibrosclerotic stroma and idiopathic retroperitoneal fibrosis who initially presented with retroperitoneal fibrosis and obstructive renal failure. One day after transsphenoidal removal of the adenoma, he developed worsening vision, confirmed as hemorrhage into the residual tumor by imaging studies, and required craniotomy.The association of MFS with pituitary adenoma has not been previously reported.Such patients may be at greater risk for hemorrhagic complications due to the consistency of the tumor and its adherence to nearby normal anatomy.

Keywords: Pituitary Adenoma, Multifocal Fibrosclerosis, Retroperitoneal Fibrosis

Paper's body in HTML will come soon.

Reference

[1]  DE Comings, KB Skubi, J Van Eyes, AG Motulsky, Familial multifocal fibrosclerosis.Ann Int Med 1967;66(5):884-892
[2]  W Fukuda, M Kimura, T Akaogi, M Sako, K Ohiwa, Y Ya-mamoto, et al, Multifocal fibrosclerosis: retroperitoneal fibrosis associated with a suprasellar tumor and pachymeningitis.Int Med 2003; 42:1006-1010
[3]  N Hatano, S Behari, T Nagatani, M Kimura, K Ooka, K Saito, et al, Idiopathic hypertrophic cranial pachymeningitis: clini-coradiological spectrum and therapeutic options.Neurosurgery 1999; 45(6):1336-1342
[4]  MJKupersmith, V Martin, G Heller, A Shah, HJ Mitnick, Idi-opathic hypertrophic pachymeningitis.Neurology 2004; 62:686-694
[5]  S Riku, S Kato, Idiopathic hypertrophic pachymeningitis. Neuropathology 2003; 23:335-344
[6]  AC Bateman, MG Deheragoda, IgG4-related systemic scle-rosing disease – an emerging and under-diagnosed condi-tion.Histopathology 2009; 55:373-383
[7]  A Khosroshahi, JH Stone, A clinical overview of IgG4-related systemic disease.CurrOpinRheumatol 2011; 23:57-66
[8]  S-K Chan, W Cheuk, K-T Chan, JKC Chan, IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease.Am J SurgPathol 2009; 33:1249-1252
[9]  Y Isaka, K Yoshioka, M Nishio, K Yamagami, Y Konishi, T Inoue, et al, A case of IgG4-related multifocal fibrosclerosis complicated by central diabetes insipidus.EndocrineJournal 2008; 55:723-728
[10]  TC Smyrk, Pathological features of IgG4-related sclerosing disease.CurrOpinRheumatol2011; 23:74-79
[11]  M Hori, N Makita, T Andoh, H Takiyama, Y Yajima, T Saka-tani, et al, Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitis.Endocrine Journal 2010; 57(6):484-492